Machine Learning Approaches to Identify Patient Comorbidities and Symptoms That Increased Risk of Mortality in COVID-19.
Machine Learning Approaches to Identify Patient Comorbidities and Symptoms That Increased Risk of Mortality in COVID-19.
复制标题
机器学习方法以识别患者合并症和症状增加COVID-19的死亡风险。
DOI:
10.3390/diagnostics11081383
复制
发表时间:
2021-07-31
期刊:
影响因子:
--
通讯作者:
Moni MA
中科院分区:
文献类型:
--
作者:
Aktar S;Talukder A;Ahamad MM;Kamal AHM;Khan JR;Protikuzzaman M;Hossain N;Azad AKM;Quinn JMW;Summers MA;Liaw T;Eapen V;Moni MA
Providing appropriate care for people suffering from COVID-19, the disease caused by the pandemic SARS-CoV-2 virus, is a significant global challenge. Many individuals who become infected may have pre-existing conditions that may interact with COVID-19 to increase symptom severity and mortality risk. COVID-19 patient comorbidities are likely to be informative regarding the individual risk of severe illness and mortality. Determining the degree to which comorbidities are associated with severe symptoms and mortality would thus greatly assist in COVID-19 care planning and provision. To assess this we performed a meta-analysis of published global literature, and machine learning predictive analysis using an aggregated COVID-19 global dataset. Our meta-analysis suggested that chronic obstructive pulmonary disease (COPD), cerebrovascular disease (CEVD), cardiovascular disease (CVD), type 2 diabetes, malignancy, and hypertension as most significantly associated with COVID-19 severity in the current published literature. Machine learning classification using novel aggregated cohort data similarly found COPD, CVD, CKD, type 2 diabetes, malignancy, and hypertension, as well as asthma, as the most significant features for classifying those deceased versus those who survived COVID-19. While age and gender were the most significant predictors of mortality, in terms of symptom–comorbidity combinations, it was observed that Pneumonia–Hypertension, Pneumonia–Diabetes, and Acute Respiratory Distress Syndrome (ARDS)–Hypertension showed the most significant associations with COVID-19 mortality. These results highlight the patient cohorts most likely to be at risk of COVID-19-related severe morbidity and mortality, which have implications for prioritization of hospital resources.
登录
查看更多内容
影响因子:
6.1
作者:
Liu, Kui;Fang, Yuan-Yuan;Liu, Hui-Guo
通讯作者:
Liu, Hui-Guo
DOI:
10.1164/rccm.202002-0445oc
发表时间:
2020-06-01
影响因子:
24.7
作者:
Feng, Yun;Ling, Yun;Qu, Jieming
通讯作者:
Qu, Jieming
影响因子:
24.3
作者:
Guan, Wei-jie;Liang, Wen-hua;He, Jian-xing
通讯作者:
He, Jian-xing
影响因子:
11.8
作者:
Ji, Dong;Zhang, Dawei;Qin, Enqiang
通讯作者:
Qin, Enqiang
影响因子:
6.1
作者:
Liu Wei;Tao Zhao-Wu;Hu Yi
通讯作者:
Hu Yi